# Etanercept in New Onset Type 1 Diabetes

> **NCT00730392** · PHASE1,PHASE2 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 18 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00730392
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2007-10
- **Final completion:** 2008-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730392, "Etanercept in New Onset Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00730392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*